ALL KEYWORDS
Hormone Therapy for Breast Cancer
Related Specialists
Showing 3 of 31
Related Fact Sheets
Related Clinical Trials
Showing 2 of 3
A pilot study to evaluate biomarkers and safety of dapagliflozin concomitant with neoadjuvant therapy for patient with HER2-negative early-stage breast cancer and hyperinsulinemia
- Breast Cancer
A Phase 1, First-in-Human Study of MEN2312, a KAT6 Inhibitor, as Monotherapy and in Combination in Participants With Advanced Breast Cancer
- Phase 1 Cancers
Related News
Related Departments
Showing 3 of 33